Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|June 15, 1997
Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in ratsY Wang, R Perfetti, N H Greig, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
Clinical pharmacokinetics of arecoline in subjects with Alzheimer's diseaseS Asthana, N H Greig, H W Holloway, et al.
Current Medical Research and Opinion|March 20, 2002
A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesteraseN H Greig, T Utsuki, Q Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug developmentK T Shaw, T Utsuki, J Rogers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2000
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humansG N Carmona, R A Jufer, S R Goldberg, et al.
Clinical & Experimental Metastasis|March 1, 1993
Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucilS Genka, J Deutsch, U H Shetty, et al.
Experimental and Clinical Psychopharmacology|September 2, 1998
Attenuation of cocaine-induced locomotor activity by butyrylcholinesteraseG N Carmona, C W Schindler, M Shoaib, et al.
Psychoneuroendocrinology|January 1, 1995
Neuroendocrine responses to intravenous infusion of arecoline in patients with Alzheimer's diseaseS Asthana, K C Raffaele, N H Greig, et al.
Pageof 8